Treatment Continuity Act of 2025
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 4
- Latest action
- Jun 17, 2025
What it does
The Treatment Continuity Act of 2025 would amend the Public Health Service Act to expand federal support for long-acting injectable medications in treating substance use disorders and serious mental illness. It would require the Secretary of Health and Human Services to prioritize access to FDA-approved long-acting injectable medications, along with lab testing, counseling, and provider training, through grants under Section 509 of the Act. The bill also mandates annual reporting to Congress on program outcomes, including progress toward treatment goals based on clinician assessments, and applies to grants made after the bill’s enactment.
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.